drugset / Trial / NCT05801900

Intravenous Ibuprofen Versus Ketorolac in Bariatric Surgery

NCT05801900

Unknown 116 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the current study is to compare the analgesic effects of both drugs in patients with obesity undergoing bariatric surgery.

Timeline

Start
2023-04
Primary completion
2023-06
Completion
2023-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 800 mg Intravenous
Comparator Ketorolac Other / unclassified 30 mg Intravenous

Indications

No indication recorded.